VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NEO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NEONeoGenomics, Inc.
$15.29$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNEOFinancials

NeoGenomics, Inc. (NEO) Income Statement

26Y historyFree accessUpdated daily

Revenue grew 11.4% to $209.3M in 2026Q3 and operating margin improved to -3.8% from -26.3% in 2025Q2, though profitability remains negative with a $7.9M operating loss.

Income StatementBalance SheetCash FlowRatios

NEO Income Statement

Annual statement

NEO Income Statement

NeoGenomics, Inc. (NEO) annual income statement — 26-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Sales/Revenue787.75M727.33M660.57M591.64M509.73M484.33M444.45M408.83M276.74M240.25M244.08M99.8M87.07M66.47M59.87M43.48M34.37M29.47M20.02M11.51M6.48M1.89M558.07K369.97K93.49K1K252.4K
Revenue Growth %11.08%10.11%11.65%16.07%5.24%8.97%8.71%47.73%15.19%-1.57%144.57%14.62%31%11.02%37.68%26.51%16.63%47.23%73.97%77.66%243.55%237.77%50.84%295.73%9249.1%-99.6%-
Cost of Goods Sold442.71M444.79M370.47M347.04M321.83M297.27M258.56M211.99M149.48M138.29M133.7M56.05M46.35M34.73M33.03M24.06M18.59M14.25M9.35M5.52M2.76M1.19M576.87K481.59K189.96K074.29K
COGS % of Revenue-61.15%56.08%58.66%63.14%61.38%58.17%51.85%54.01%57.56%54.78%56.16%53.24%52.25%55.17%55.32%54.08%48.37%46.73%48.01%42.6%63.02%103.37%130.17%203.18%-29.43%
Gross Profit345.04M282.54M290.1M244.6M187.9M187.06M185.89M196.84M127.27M101.96M110.38M43.76M40.71M47.8K26.84M19.43M15.78M15.21M10.66M5.98M3.72M696.92K-18.79K-112K-96.47K1K178.11K
Gross Margin %43.8%38.85%43.92%41.34%36.86%38.62%41.83%48.15%45.99%42.44%45.22%43.84%46.76%0.07%44.83%44.68%45.92%51.63%53.27%51.99%57.4%36.97%-3.37%-30.27%-103.18%100%70.57%
Gross Profit Growth %--2.61%18.6%30.18%0.45%0.63%-5.56%54.67%24.82%-7.63%152.26%7.47%85075.73%-99.82%38.13%23.09%3.73%42.72%78.22%60.94%433.35%3808.41%83.22%-16.1%-9746.7%-99.44%-
Operating Expenses392.13M348.62M382.21M352.34M345.52M305.81M199.88M183.83M117.22M99.05M95.95M49.39M38.5M28.56M25.63M19.84M18.75M16.94M11.54M9.12M3.58M1.5M710.77K382.71K487.21K8.08M1.15M
OpEx % of Revenue-47.93%57.86%59.55%67.78%63.14%44.97%44.96%42.36%41.23%39.31%49.49%44.21%42.97%42.8%45.62%54.54%57.49%57.68%79.3%55.23%79.42%127.36%103.44%521.13%807900%455.22%
Selling, General & Admin362.08M365.34M310.49M279.96M277.91M283.94M191.66M175.34M114.22M113.3M87.84M45.19M35.81M26.12M23.34M19.84M18.75M16.94M11.54M9.12M3.58M1.5M710.77K382.71K440.79K8.08M1.12M
SG&A % of Revenue-50.23%47%47.32%54.52%58.63%43.12%42.89%41.27%47.16%35.99%45.28%41.12%39.3%38.99%45.62%54.54%57.49%57.68%79.3%55.23%79.42%127.36%103.44%471.48%807900%444.92%
Research & Development39.33M37.08M31.16M27.31M30.33M21.87M8.23M8.49M3M3.64M4.65M4.2M2.69M2.44M2.28M543K0000000046.41K00
R&D % of Revenue-5.1%4.72%4.62%5.95%4.52%1.85%2.08%1.08%1.51%1.9%4.21%3.09%3.67%3.81%1.25%--------49.65%--
Other Operating Expenses-1000K-53.8M40.55M45.07M37.29M00014K1.06M3.46M00000000000000026.4K
Operating Income-47.09M-66.08M-92.11M-107.74M-157.62M-118.75M-13.99M13.01M10.04M2.9M2.57M-5.63M2.22M3.17M1.21M-409K-2.96M-1.73M-884K-3.14M139.99K-800K-730K-494K-584K-8.08M-971K
Operating Margin %-5.98%-9.09%-13.94%-18.21%-30.92%-24.52%-3.15%3.18%3.63%1.21%1.05%-5.65%2.55%4.78%2.02%-0.94%-8.62%-5.86%-4.42%-27.3%2.16%-42.44%-130.81%-133.52%-624.66%-807800%-384.7%
Operating Income Growth %-28.26%14.51%31.65%-32.73%-748.73%-207.58%29.54%245.97%12.74%145.68%-354.06%-30.12%162.1%396.09%86.2%-71.47%-95.48%71.86%-2343.67%117.5%-9.59%-47.77%15.41%92.77%-731.93%-
EBITDA18.11M1.75M-19.56M-35.15M-88.19M-65.4M21.73M43.28M31.77M25.49M25.78M1.51M7.86M7.59M5.03M1.68M-1.18M-544K-143.44K-2.63M446.58K-618.93K-625.74K-445.96K-791K-7.83M-944.6K
EBITDA Margin %2.3%0.24%-2.96%-5.94%-17.3%-13.5%4.89%10.59%11.48%10.61%10.56%1.51%9.03%11.41%8.4%3.85%-3.44%-1.85%-0.72%-22.9%6.9%-32.83%-112.12%-120.54%-846.07%-783232.9%-374.24%
EBITDA Growth %135.34%108.92%44.36%60.14%-34.85%-400.99%-49.79%36.21%24.63%-1.12%1610.88%-80.82%3.59%50.85%200.06%241.79%-117.28%-279.26%94.56%-689.96%172.15%1.09%-40.31%43.62%89.9%-729.17%-
D&A (Non-Cash Add-back)65.21M67.82M72.55M72.58M69.43M53.35M35.72M30.27M21.73M22.59M23.21M7.14M5.64M4.41M3.82M2.08M1.78M1.18M740.56K506.36K306.59K181.07K104.26K48.04K-207K245.67K26.4K
EBIT-32.93M-106.52M-74.06M-90.19M-151.76M-6.86M-7.04M7.36M10.04M3.96M2.15M-3.63M2.22M3.17M1.21M-409K-2.96M-1.73M-884K-3.14M139.99K-800K-730K-494K-584K-8.08M-971K
Net Interest Income1.96M5.32M11.81M9.99M-1.51M-5.08M-7.02M-3.71M-6.23M-5.54M-10M-854K-985K-989K-1.15M-768K-710K-532K-309K0-326K-197K0-41.43K000
Interest Income5.21M9.07M18.43M16.9M6.08M3.14M000000000000000000000
Interest Expense3.25M3.75M6.62M6.91M7.58M8.22M7.02M3.71M6.23M5.54M10M854K985K989K1.15M768K710K532.39K308.52K0325.63K196.8K041.43K207.31K00
Other Income/Expense10.91M-44.19M11.43M10.64M-1.72M103.68M-64K-9.36M-6.22M-5.55M-10M1.15M-929K-989K-1.15M-768K-1K0-499K-239K-140K-197K-89.42K000646
Pretax Income-36.18M-110.27M-80.67M-97.1M-159.34M-15.07M-14.06M3.65M3.82M-2.65M-7.42M-4.49M1.29M2.19M65K-2.7K-3.3M-2.24M-1.07M-3.12M-130K-997K-819K000-970K
Pretax Margin %-4.59%-15.16%-12.21%-16.41%-31.26%-3.11%-3.16%0.89%1.38%-1.1%-3.04%-4.5%1.48%3.29%0.11%-0.01%-9.61%-7.61%-5.37%-27.09%-2.01%-52.89%-146.75%----384.31%
Income Tax-3.88M-2.24M-1.95M-9.13M-15.09M-6.73M-18.23M-4.36M1.18M-2.25M-1.7M-1.95M157K152K0768K-740K-34.18K180.15K214.94K-112K0041.43K214.16K0-1.29K
Effective Tax Rate %10.74%2.03%2.42%9.4%9.47%44.63%129.68%-119.64%30.96%85.06%22.91%43.53%12.18%6.96%0%-28444.44%22.4%1.52%-16.77%-6.9%86.15%0%0%---0.13%
Net Income-32.3M-108.03M-78.73M-87.97M-144.25M-8.35M4.17M8.01M2.64M-396K-6.14M-2.54M1.13M2.03M65K-1.18M-3.3M-2.24M-1.38M-3.38M-130K-997K-819K-536K-591K-8.08M-970K
Net Margin %-4.1%-14.85%-11.92%-14.87%-28.3%-1.72%0.94%1.96%0.95%-0.16%-2.52%-2.54%1.3%3.06%0.11%-2.71%-9.61%-7.61%-6.91%-29.38%-2.01%-52.89%-146.75%-144.88%-632.15%-807800%-384.31%
Net Income Growth %71.54%-37.22%10.51%39.02%-1628.17%-300.07%-47.89%203.26%766.67%93.55%-142.29%-323.94%-44.32%3027.69%105.52%64.37%-47.26%-62.18%59.08%-2500%86.96%-21.73%-52.8%9.31%92.68%-732.78%-
Net Income (Continuing)-32.3M-108.03M-78.73M-87.97M-144.25M-8.35M4.17M8.01M2.64M-396K-5.72M-2.54M1.13M2.03M65K-1.18M-3.3M-2.24M-1.38M-3.38M-130K-997K-819K-536K-591K-8.08M-970K
Discontinued Operations000000000000000000000000000
Minority Interest000000000000000000000000000
EPS (Diluted)-0.25-0.84-0.62-0.70-1.16-0.070.040.080.03-0.01-0.08-0.210.100.200.01-0.14-0.44-0.32-0.22-0.55-0.03-0.22-0.20-0.19-0.70-10.70-6.20
EPS Growth %71.95%-35.48%11.43%39.66%-1566.67%-286.6%-51.75%168.4%-93.69%62.29%-310%-50%-104.64%68.18%-37.5%-45.45%60%-2100%88.64%-10%-5.26%72.86%93.46%-72.58%-
EPS (Basic)--0.84-0.62-0.70-1.16-0.070.040.080.03-0.01-0.08-0.210.100.200.01-0.14-0.44-0.32-0.22-0.55-0.03-0.22-0.20-0.19-0.70-2.15-1.25
Diluted Shares Outstanding128.59M128.1M126.66M125.5M124.22M119.96M111.79M103.61M91.57M79.43M77.54M12.11M11.2M10.55M9.74M8.55M7.47M6.93M6.3M6.27M5.23M4.51M4.16M2.88M857.6K754.2K156.4K
Basic Shares Outstanding128.59M128.1M126.66M125.5M124.22M119.96M108.58M100.47M91.57M79.43M77.54M12.11M11.32M10.16M9.75M8.55M7.47M6.93M6.3M6.27M5.23M4.51M4.16M2.88M857.6K3.77M782K
Dividend Payout Ratio---------------------------

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Persistent operating losses at scale

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Steady Double-Digit Top-Line Expansion Persists

Based on reported income statement figures, NEO's revenue grew 11.4% year over year to $209.3M in the latest quarter, indicating durable demand despite a sequential slowdown in the 7.5% to 12% range seen across recent periods.

The revenue series shows consistent expansion from $164.5M in 2024Q2 to $209.3M in 2026Q3, with year-over-year growth clustering around 10% to 12% for most of the window. This pattern suggests volume-driven demand rather than a single pricing event, though the reported figures do not allow separation of volume from price effects. Investors should monitor whether growth sustains at this rate, since the 2025Q1 dip to 7.5% warranted attention.

Gross Margin Recovery Lags Revenue Growth

As reported in financial statements, NEO's gross margin rebounded from a 39.8% low in 2025Q4 to 46.2% in 2026Q3, yet remains below the 44.9% to 46.2% range management's pricing trajectory would need to fully offset fixed costs.

Gross margin moved within a relatively narrow band of roughly 40% to 46% over the period, with the 2025Q4 trough suggesting sensitivity to cost of goods sold timing or mix. The recent recovery to 46.2% indicates improving unit economics, but the reported data does not isolate pricing power relative to peers. Peer gross margins in the supplied set range widely, so the comparison is limited by differing business models.

Operating Leverage Remains Negative Despite Scale

Based on NEO's reported figures, operating margin improved from -26.3% in 2025Q2 to -3.8% in 2026Q3, suggesting operating income is beginning to scale faster than revenue as SG&A held near $90M to $95M.

SG&A stayed roughly flat in the $85M to $96M range while revenue grew about 25% across the window, which is the core source of margin improvement. This suggests overhead efficiency is emerging, though the company has not yet reached operating breakeven on a sustained basis. The narrowing loss implies operating leverage is working in the right direction but has not yet proven durable.

Reported Profit Volatile and Share-Count Sensitive

According to reported filings, NEO's diluted EPS swung from -$1.75 in 2025Q2 to +$0.02 in 2026Q2 before returning to -$0.06, a pattern that may reflect non-operating items and share-count effects rather than steady earnings power.

Net income turned positive in 2026Q2 at $2.2M while operating income remained negative, suggesting non-operating items or tax effects contributed to that quarter. Stock-based compensation of $8M to $12M per quarter represents a material cost that may depress reported earnings quality relative to cash-based measures. The volatility warrants further investigation before treating any single quarter as a reliable earnings signal.

Margin Recovery May Stall at Current Levels

Based on reported figures, the bear case centers on whether NEO's operating loss of $7.9M in 2026Q3 can close, since revenue growth alone has not produced sustained profitability over ten quarters of reported data.

Operating losses have persisted in every quarter of the supplied history, and the latest quarter's operating margin of -3.8% still implies cost structure gaps. Short-side analysis would argue that SG&A growth of $94.7M against revenue growth may limit leverage if top-line growth decelerates. Investors should monitor whether gross margin can hold above 45% while SG&A stays flat, since failure on either front would extend the loss period.

NEO — Frequently Asked Questions

Quick answers to the most common questions about buying NEO stock.

What was NeoGenomics, Inc.'s (NEO) revenue in 2025?

For fiscal year 2025, NeoGenomics, Inc. (NEO) reported total revenue of $727.3M. This represents a 288063.0% increase compared to $0.3M in 2000.

Is NeoGenomics, Inc. (NEO) profitable?

NeoGenomics, Inc. (NEO) reported a net loss of $108.0M for the fiscal year ending 2025.

What is NeoGenomics, Inc.'s operating profit margin?

NeoGenomics, Inc. (NEO) reported an operating income of $-66.1M, resulting in an operating profit margin of -9.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is NeoGenomics, Inc.'s gross profit and gross margin?

NeoGenomics, Inc. (NEO) generated $282.5M in gross profit for the year, representing a gross profit margin of 38.8%. This demonstrates the company's core pricing power and production efficiency.